Medtronic Provides Update on June Recall of Its Cobalt and Crome Devices

Medtronic has issued an update on its June 3 recall of its Cobalt and Crome implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.

The implanted devices are for patients at significant risk of developing atrial or ventricular arrhythmias and who have heart failure with ventricular arrhythmias.

Medtronic has released a software update to address the issue, but patients will need to do an in-clinic visit for the update to be installed.

The company said there is a risk of reduced shock energy, down to approximately 79 percent of the programmed energy, during high-voltage therapy.

Medtronic said it has not received any reports of permanent injury or death due to the issue.